MetaSight

Acquired

Tel Aviv, Israel · $8.0M raised

Headquarters
Tel Aviv
Employees
11–50
Business Model
B2B
Total Funding
$8.0M
Last Round
$8.0M Series ANov 2024
Rounds
1

About

Develops blood-based metabolomic diagnostics to detect colorectal and other cancers for healthcare providers.

Summary

MetaSight is a Diagnostics company based in Tel Aviv, Israel. It has raised $8.0M in total across 1 round, most recently a $8.0M Series A round in Nov 2024. Investors include Guardant Health, aMoon and Saban Ventures.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

AcquisitionAcquisition by Guardant HealthFeb 2026

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies